- Home
- EVGN vs NRXS Comparison
EVGN vs NRXS Comparison
Compare EVGN & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVGN
- NRXS
- Stock Information
- Founded
- EVGN 1999
- NRXS 2011
- Country
- EVGN Israel
- NRXS United States
- Employees
- EVGN N/A
- NRXS N/A
- Industry
- EVGN Agricultural Chemicals
- NRXS
- Sector
- EVGN Industrials
- NRXS
- Exchange
- EVGN Nasdaq
- NRXS Nasdaq
- Market Cap
- EVGN 11.3M
- NRXS 13.0M
- IPO Year
- EVGN N/A
- NRXS 2023
- Fundamental
- Price
- EVGN $1.33
- NRXS $2.60
- Analyst Decision
- EVGN Strong Buy
- NRXS Strong Buy
- Analyst Count
- EVGN 1
- NRXS 1
- Target Price
- EVGN $3.50
- NRXS $7.00
- AVG Volume (30 Days)
- EVGN 5.5M
- NRXS 137.3K
- Earning Date
- EVGN 08-21-2025
- NRXS 08-08-2025
- Dividend Yield
- EVGN N/A
- NRXS N/A
- EPS Growth
- EVGN N/A
- NRXS N/A
- EPS
- EVGN N/A
- NRXS N/A
- Revenue
- EVGN $6,765,000.00
- NRXS $2,934,945.00
- Revenue This Year
- EVGN N/A
- NRXS $138,883.78
- Revenue Next Year
- EVGN $113.18
- NRXS $118.59
- P/E Ratio
- EVGN N/A
- NRXS N/A
- Revenue Growth
- EVGN N/A
- NRXS 27.52
- 52 Week Low
- EVGN $0.95
- NRXS $1.33
- 52 Week High
- EVGN $6.80
- NRXS $6.20
- Technical
- Relative Strength Index (RSI)
- EVGN 49.73
- NRXS 52.91
- Support Level
- EVGN $1.26
- NRXS $2.32
- Resistance Level
- EVGN $1.44
- NRXS $2.65
- Average True Range (ATR)
- EVGN 0.11
- NRXS 0.15
- MACD
- EVGN -0.02
- NRXS -0.01
- Stochastic Oscillator
- EVGN 21.62
- NRXS 78.05
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).